Status:
COMPLETED
Screening for HIV-Associated Anal Cancer
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Ontario HIV Treatment Network
Canadian Foundation for AIDS Research (CANFAR)
Conditions:
HIV Infections
Anal Cancer
Eligibility:
MALE
18+ years
Brief Summary
Cancer of the anus occurs at very high rates in young men with HIV and is caused by a virus called human papillomavirus (HPV). Anal cancer has increased during the HIV epidemic despite effective thera...
Detailed Description
Anal cancer occurs at a rate which is 163-fold greater in young men with HIV. It is caused by another virus, HPV. The incidence has doubled during the HIV epidemic and is not decreasing despite effect...
Eligibility Criteria
Inclusion
- HIV-infected men,
- History of anal receptive intercourse,
- Minimum age 18 years.
Exclusion
- Known anal cancer,
- Bleeding diathesis that might preclude anoscopy and biopsy.
Key Trial Info
Start Date :
August 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
401 Patients enrolled
Trial Details
Trial ID
NCT00188292
Start Date
August 1 2002
End Date
June 1 2012
Last Update
March 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4